$ONC
BeiGene, Ltd.

2022 Q4 Form 10-Q Financial Statement

#000165130822000209 Filed on November 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $2.698B $387.6M
YoY Change 98.0% 87.77%
Cost Of Revenue $501.9M $76.54M
YoY Change 52.43% 61.44%
Gross Profit $2.196B $311.1M
YoY Change 112.52% 95.62%
Gross Profit Margin 81.39% 80.25%
Selling, General & Admin $2.367B $322.9M
YoY Change 7.91% 19.93%
% of Gross Profit 107.81% 103.8%
Research & Development $3.135B $426.4M
YoY Change 10.96% 21.15%
% of Gross Profit 142.76% 137.06%
Depreciation & Amortization $15.21M
YoY Change 29.23%
% of Gross Profit 4.89%
Operating Expenses $5.519B $749.3M
YoY Change 6.59% 20.62%
Operating Profit -$3.323B -$438.4M
YoY Change -19.82% -5.18%
Interest Expense $246.5M -$858.7M
YoY Change -307.01% -757.06%
% of Operating Profit
Other Income/Expense, Net -$1.219M -$125.6M
YoY Change -524.74% -499.15%
Pretax Income -$3.078B -$551.2M
YoY Change -27.82% 27.28%
Income Tax $130.8M $6.318M
% Of Pretax Income
Net Earnings -$3.208B -$557.6M
YoY Change -24.46% 34.72%
Net Earnings / Revenue -118.93% -143.84%
Basic Earnings Per Share -$0.41
Diluted Earnings Per Share -$2.38 -$0.41
COMMON SHARES
Basic Shares Outstanding 1.350B shares 1.350B shares
Diluted Shares Outstanding 1.345B shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.79B $28.97B
YoY Change 304.86% 639.73%
Cash & Equivalents $3.870B $4.197B
Short-Term Investments $6.659B $2.653B
Other Short-Term Assets $6.136B $8.517B
YoY Change 22575.15% 684.49%
Inventory $282.3M $290.9M
Prepaid Expenses
Receivables $173.2M $189.2M
Other Receivables $89.94M $51.31M
Total Short-Term Assets $5.207B $5.749B
YoY Change -31.61% 29.7%
LONG-TERM ASSETS
Property, Plant & Equipment $845.9M $681.9M
YoY Change 43.97% 51.27%
Goodwill $109.0K $109.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $27.71M $25.79M
YoY Change 20.71% -95.45%
Other Assets $170.4M $140.6M
YoY Change 4.52% -19.74%
Total Long-Term Assets $1.172B $976.8M
YoY Change 13.58% 14.45%
TOTAL ASSETS
Total Short-Term Assets $5.207B $5.749B
Total Long-Term Assets $1.172B $976.8M
Total Assets $6.379B $6.726B
YoY Change -26.22% 27.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $294.8M $252.1M
YoY Change 12.34% 22.24%
Accrued Expenses $467.4M $410.3M
YoY Change -16.25% 5.23%
Deferred Revenue $213.9M $145.0M
YoY Change 14.11% 99.63%
Short-Term Debt $2.203B $2.977B
YoY Change -15.99% 7.86%
Long-Term Debt Due 2.269B cnies $441.3M
YoY Change -16.73% -84.52%
Total Short-Term Liabilities $1.469B $1.411B
YoY Change -8.19% 8.19%
LONG-TERM LIABILITIES
Long-Term Debt 1.443B cnies $208.1M
YoY Change 12.0% -83.93%
Other Long-Term Liabilities $46.10M $45.17M
YoY Change -15.01% -17.28%
Total Long-Term Liabilities $527.4M $659.5M
YoY Change -34.35% 5.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.469B $1.411B
Total Long-Term Liabilities $527.4M $659.5M
Total Liabilities $1.996B $2.071B
YoY Change -16.94% 7.34%
SHAREHOLDERS EQUITY
Retained Earnings -$7.080B -$6.635B
YoY Change 42.57% 51.47%
Common Stock $135.0K $135.0K
YoY Change 1.5% 11.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.383B $4.655B
YoY Change
Total Liabilities & Shareholders Equity $6.379B $6.726B
YoY Change -26.22% 27.23%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$3.208B -$557.6M
YoY Change -24.46% 34.72%
Depreciation, Depletion And Amortization $15.21M
YoY Change 29.23%
Cash From Operating Activities -$1.341B -$3.122B
YoY Change -56.88% -3.3%
INVESTING ACTIVITIES
Capital Expenditures $861.3M -$723.7M
YoY Change -169.45% 77.82%
Acquisitions
YoY Change
Other Investing Activities -$3.814B $1.474B
YoY Change -1747.16% 9.85%
Cash From Investing Activities -$4.675B $750.2M
YoY Change 363.55% -19.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -891.3M 750.3M
YoY Change -104.15% 18.68%
NET CHANGE
Cash From Operating Activities -1.341B -3.122B
Cash From Investing Activities -4.675B 750.2M
Cash From Financing Activities -891.3M 750.3M
Net Change In Cash -6.908B -1.621B
YoY Change -139.83% -2.42%
FREE CASH FLOW
Cash From Operating Activities -$1.341B -$3.122B
Capital Expenditures $861.3M -$723.7M
Free Cash Flow -$2.202B -$2.398B
YoY Change 17.82% -15.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei City Area Code
CityAreaCode
345
dei Entity Central Index Key
EntityCentralIndexKey
0001651308
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37686
dei Entity Registrant Name
EntityRegistrantName
BEIGENE, LTD.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1209416
dei Entity Address Address Line1
EntityAddressAddressLine1
c/o Mourant Governance Services (Cayman) Limited
dei Entity Address Address Line2
EntityAddressAddressLine2
94 Solaris Avenue, Camana Bay
dei Entity Address City Or Town
EntityAddressCityOrTown
Grand Cayman
dei Entity Address Country
EntityAddressCountry
KY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
KY1-1108
dei Local Phone Number
LocalPhoneNumber
949-4123
dei Security12b Title
Security12bTitle
American Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
BGNE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1349640180 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4197132000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4375678000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
191000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
328000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
871998000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
2241962000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
189170000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
483113000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
290911000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
242626000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
199766000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
270173000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
5749168000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
7613880000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3189000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
6881000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
681914000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
587605000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
110340000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
117431000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40849000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46679000 usd
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
140553000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
163049000 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
976845000 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
921645000 usd
CY2022Q3 us-gaap Assets
Assets
6726013000 usd
CY2021Q4 us-gaap Assets
Assets
8535525000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
252071000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
262400000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
410255000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
558055000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
144984000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
187414000 usd
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
22665000 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
21395000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24340000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21925000 usd
CY2022Q3 bgne Research And Development Cost Share Liability Current Portion
ResearchAndDevelopmentCostShareLiabilityCurrentPortion
115721000 usd
CY2021Q4 bgne Research And Development Cost Share Liability Current Portion
ResearchAndDevelopmentCostShareLiabilityCurrentPortion
120801000 usd
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
441275000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
427565000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1411311000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1599555000 usd
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
208058000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
202113000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
149899000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
220289000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
36904000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43041000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15249000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
14169000 usd
CY2022Q3 bgne Research And Development Cost Share Liability Noncurrent Portion
ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion
204252000 usd
CY2021Q4 bgne Research And Development Cost Share Liability Noncurrent Portion
ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion
269561000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
45169000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
54234000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
659531000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
803407000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
2070842000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2402962000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1349640180 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1349640180 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1334804281 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1334804281 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
135000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
133000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11451566000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11191007000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-161523000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17950000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6635007000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5076527000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
4655171000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6132563000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6726013000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8535525000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
387628000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
206440000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1035826000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
962304000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
76543000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
47413000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
212953000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
116361000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
426363000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
351937000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1194485000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1028754000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
322892000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
269227000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
948868000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
683622000 usd
CY2022Q3 bgne Amortization Of Intangible Assets Included In Operating Expenses
AmortizationOfIntangibleAssetsIncludedInOperatingExpenses
187000 usd
CY2021Q3 bgne Amortization Of Intangible Assets Included In Operating Expenses
AmortizationOfIntangibleAssetsIncludedInOperatingExpenses
188000 usd
bgne Amortization Of Intangible Assets Included In Operating Expenses
AmortizationOfIntangibleAssetsIncludedInOperatingExpenses
563000 usd
bgne Amortization Of Intangible Assets Included In Operating Expenses
AmortizationOfIntangibleAssetsIncludedInOperatingExpenses
563000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
825985000 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
668765000 usd
us-gaap Costs And Expenses
CostsAndExpenses
2356869000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1829300000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-438357000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-462325000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1321043000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-866996000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12759000 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2230000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
34261000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-11275000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-125640000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31477000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-243290000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26487000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-551238000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-433078000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1530072000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-851784000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6318000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5036000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28408000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15354000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-557556000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-438114000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1558480000 usd
us-gaap Net Income Loss
NetIncomeLoss
-867138000 usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1345303747 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1345303747 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1205971284 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1205971284 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1337976853 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1337976853 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1196391201 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1196391201 shares
CY2022Q3 bgne Earnings Per American Depository Share Diluted
EarningsPerAmericanDepositoryShareDiluted
-5.39
CY2022Q3 bgne Earnings Per American Depository Share Basic
EarningsPerAmericanDepositoryShareBasic
-5.39
CY2021Q3 bgne Earnings Per American Depository Share Diluted
EarningsPerAmericanDepositoryShareDiluted
-4.72
CY2021Q3 bgne Earnings Per American Depository Share Basic
EarningsPerAmericanDepositoryShareBasic
-4.72
bgne Earnings Per American Depository Share Diluted
EarningsPerAmericanDepositoryShareDiluted
-15.14
bgne Earnings Per American Depository Share Basic
EarningsPerAmericanDepositoryShareBasic
-15.14
bgne Earnings Per American Depository Share Diluted
EarningsPerAmericanDepositoryShareDiluted
-9.42
bgne Earnings Per American Depository Share Basic
EarningsPerAmericanDepositoryShareBasic
-9.42
CY2022Q3 bgne Weighted Average Number Of American Depository Shares Outstanding Basic
WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic
103484904 shares
CY2022Q3 bgne Weighted Average Number Of American Depository Shares Outstanding Diluted
WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted
103484904 shares
CY2021Q3 bgne Weighted Average Number Of American Depository Shares Outstanding Basic
WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic
92767022 shares
CY2021Q3 bgne Weighted Average Number Of American Depository Shares Outstanding Diluted
WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted
92767022 shares
bgne Weighted Average Number Of American Depository Shares Outstanding Diluted
WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted
102921296 shares
bgne Weighted Average Number Of American Depository Shares Outstanding Basic
WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic
102921296 shares
bgne Weighted Average Number Of American Depository Shares Outstanding Basic
WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic
92030092 shares
bgne Weighted Average Number Of American Depository Shares Outstanding Diluted
WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted
92030092 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-557556000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-438114000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1558480000 usd
us-gaap Net Income Loss
NetIncomeLoss
-867138000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-80326000 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
664000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-168411000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
6528000 usd
CY2022Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2021Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
111000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-250000 usd
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1253000 usd
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-68000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-11062000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1140000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-636629000 usd
us-gaap Net Income Loss
NetIncomeLoss
-867138000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-437629000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1737953000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-861500000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1558480000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48262000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33336000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
225036000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
177701000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-16413000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17166000 usd
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
20000000 usd
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
53500000 usd
bgne Amortization Of Research And Development Financing Liability
AmortizationOfResearchAndDevelopmentFinancingLiability
-70389000 usd
bgne Amortization Of Research And Development Financing Liability
AmortizationOfResearchAndDevelopmentFinancingLiability
-82846000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
380000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
2474000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
7762000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
17719000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-284717000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
69174000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
75632000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
61686000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-30325000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
92489000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4203000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-12376000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1628000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-44000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-112820000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
124898000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
167000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2407000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1178428000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-790884000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
204076000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
147963000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
14735000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2062879000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1352398000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
2758391000 usd
bgne Payments To Purchase In Process Research And Development
PaymentsToPurchaseInProcessResearchAndDevelopment
95000000 usd
bgne Payments To Purchase In Process Research And Development
PaymentsToPurchaseInProcessResearchAndDevelopment
8500000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
7500000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1038587000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
531549000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
37372000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
16838000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
163774000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
143456000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
145428000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
40229000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
35677000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
82192000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
91395000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
252257000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-133929000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6769000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-182375000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-309000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4382887000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1390005000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4200512000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1389696000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4197132000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1383310000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
191000 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
330000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3189000 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
6056000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
25006000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15214000 usd
us-gaap Interest Paid Net
InterestPaidNet
19865000 usd
us-gaap Interest Paid Net
InterestPaidNet
23398000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
47310000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
41897000 usd
bgne Acquired In Process Research And Development But Not Yet Paid
AcquiredInProcessResearchAndDevelopmentButNotYetPaid
0 usd
bgne Acquired In Process Research And Development But Not Yet Paid
AcquiredInProcessResearchAndDevelopmentButNotYetPaid
45000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6132563000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
152000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
11880000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
65555000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-496000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-435198000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5774152000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
7092000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81305000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-99904000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-565726000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5196919000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
16705000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
78176000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-79073000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-557556000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4655171000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3803281000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
25754000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45833000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3738000 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
55580000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3926710000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
9847000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
64791000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8891000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-484604000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3525635000 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
46591000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
67077000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
485000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-438114000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3251674000 usd
CY2022Q3 bgne Number Of Persons
NumberOfPersons
2500 people
CY2022Q3 bgne Product Candidate
ProductCandidate
3 product
CY2022Q3 dei Entity Number Of Employees
EntityNumberOfEmployees
9000 employee
CY2022Q3 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
29 country
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, estimating the useful lives of long-lived assets, estimating variable consideration in product sales and collaboration revenue arrangements, identifying separate accounting units and determining the standalone selling price of each performance obligation in the Company’s revenue arrangements, assessing the impairment of long-lived assets, valuation and recognition of share-based compensation expenses, realizability of deferred tax assets, estimating uncertain tax positions, valuation of inventory, estimating the allowance for credit losses, determining defined benefit pension plan obligations, measurement of right-of-use assets and lease liabilities and the fair value of financial instruments. Management bases the estimates on historical experience, known trends and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities and reported amounts of revenues and expenses. Actual results could differ from these estimates.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revision of prior period financial statements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company evaluates the recoverability of its deferred tax assets on a jurisdiction-by-jurisdiction basis by assessing the adequacy of future expected taxable income from all sources, including reversal of temporary differences, forecasted operating earnings and available tax planning strategies in accordance with ASC 740. This assessment is subject to a high degree of subjectivity, as the sources of income rely heavily on estimates that are based on a number of factors, including historical experience and short-range and long-range business forecasts. A valuation allowance is provided when the Company determines that it is more-likely-than-not that some portion or all of a deferred tax asset will not be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prior to the third quarter of 2022, the Company determined that the majority of its net deferred tax assets (primarily in the U.S.) were realizable on a more-likely-than-not basis, primarily due to cumulative pre-tax income at the taxpaying entity and the weighting of available positive and negative evidence. Accordingly, no valuation allowance was previously recorded related to those deferred tax assets. In October 2022, in connection with the preparation of its condensed consolidated financial statements for the three and nine months ended September 30, 2022, the Company reassessed its position on the realizability of its net deferred tax assets and determined that the negative evidence associated with cumulative losses at the consolidated financial statement level are not able to be overcome by other positive evidence, and therefore, a valuation allowance should be applied to its net deferred tax asset balance. The Company determined the previous conclusion to not apply a valuation allowance to certain net deferred tax assets was an error. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with Staff Accounting Bulletin (SAB) No. 99, “Materiality,” and SAB No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” the Company evaluated the error and determined that the related impact was not material to any of its previously issued financial statements, but that correcting the cumulative impact of the error would be significant to its statements of operations for the three and nine months ended September 30, 2022. Accordingly, the Company has revised the first and second quarters of 2022 and the quarterly and annual periods of fiscal year 2021 condensed consolidated financial statements and related notes included herein to record a valuation allowance against the Company’s net deferred tax asset balance for all periods presented. A summary of revisions to previously reported financial statements is presented in Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revision of Prior Period Financial Statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> have been updated to reflect the revision. The Company will also correct previously reported financial information for this error in its future filings, as applicable.</span></div>
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
921645000 usd
CY2021Q4 us-gaap Assets
Assets
8535525000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5076527000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6132563000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8535525000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5036000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15354000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-438114000 usd
us-gaap Net Income Loss
NetIncomeLoss
-867138000 usd
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2021Q3 bgne Earnings Per American Depository Share Basic
EarningsPerAmericanDepositoryShareBasic
-4.72
CY2021Q3 bgne Earnings Per American Depository Share Diluted
EarningsPerAmericanDepositoryShareDiluted
-4.72
bgne Earnings Per American Depository Share Basic
EarningsPerAmericanDepositoryShareBasic
-9.42
bgne Earnings Per American Depository Share Diluted
EarningsPerAmericanDepositoryShareDiluted
-9.42
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-438114000 usd
us-gaap Net Income Loss
NetIncomeLoss
-867138000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-437629000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-861500000 usd
us-gaap Net Income Loss
NetIncomeLoss
-867138000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
2474000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
92489000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-44000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2407000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-790884000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6132563000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-435198000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5774152000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-565726000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5196919000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3803281000 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
55580000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3926710000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-484604000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3525635000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-438114000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3251674000 usd
CY2022Q1 bgne Number Of Products Initiated Marketing And Promotion
NumberOfProductsInitiatedMarketingAndPromotion
5 product
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3700000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
2241962000 usd
CY2022Q3 bgne Reimbursement Expense
ReimbursementExpense
14660000 usd
CY2021Q3 bgne Reimbursement Expense
ReimbursementExpense
12545000 usd
bgne Reimbursement Expense
ReimbursementExpense
36926000 usd
bgne Reimbursement Expense
ReimbursementExpense
27721000 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
3380000 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
7209000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
883126000 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
11128000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
871998000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
2245662000 usd
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
56789000 usd
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
43722000 usd
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
4699000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
5065000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
25787000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
22955000 usd
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
88953000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
78140000 usd
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
22737000 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9397000 usd
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
179221000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
155089000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
290911000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
242626000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
609413000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
525048000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
149692000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
124286000 usd
CY2022Q3 bgne Construction In Progress Net
ConstructionInProgressNet
222193000 usd
CY2021Q4 bgne Construction In Progress Net
ConstructionInProgressNet
186843000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
681914000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
587605000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
15214000 usd
us-gaap Depreciation
Depreciation
45255000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
11773000 usd
us-gaap Depreciation
Depreciation
32440000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
48748000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7899000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40849000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
51710000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5031000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46679000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
987000 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
404000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3007000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
896000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
967000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3867000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3867000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3867000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3867000 usd
CY2022Q3 bgne Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
24414000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40849000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6318000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28408000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5036000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15354000 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
12725000 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
960000 usd
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
2800000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
415000 usd
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
112000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-161000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-7000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 usd
bgne Accounts Receivable Allowance For Credit Loss Exchange Rate Changes
AccountsReceivableAllowanceForCreditLossExchangeRateChanges
-2000 usd
bgne Accounts Receivable Allowance For Credit Loss Exchange Rate Changes
AccountsReceivableAllowanceForCreditLossExchangeRateChanges
3000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
252000 usd
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
108000 usd
CY2022Q3 bgne Prepaid Research And Development Costs
PrepaidResearchAndDevelopmentCosts
74575000 usd
CY2021Q4 bgne Prepaid Research And Development Costs
PrepaidResearchAndDevelopmentCosts
87239000 usd
CY2022Q3 bgne Prepaid Manufacturing Costs
PrepaidManufacturingCosts
60971000 usd
CY2021Q4 bgne Prepaid Manufacturing Costs
PrepaidManufacturingCosts
78538000 usd
CY2022Q3 us-gaap Prepaid Taxes
PrepaidTaxes
11494000 usd
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
58579000 usd
CY2022Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
11272000 usd
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
12010000 usd
CY2022Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
2203000 usd
CY2021Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
5052000 usd
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
6465000 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1695000 usd
CY2022Q3 bgne Short Term Deposits
ShortTermDeposits
10917000 usd
CY2021Q4 bgne Short Term Deposits
ShortTermDeposits
2982000 usd
CY2022Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
21869000 usd
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
24078000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
199766000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
270173000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
109000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
109000 usd
CY2022Q3 bgne Prepayment Of Long Term Asset
PrepaymentOfLongTermAsset
17951000 usd
CY2021Q4 bgne Prepayment Of Long Term Asset
PrepaymentOfLongTermAsset
14140000 usd
CY2022Q3 bgne Prepaid Construction Cost
PrepaidConstructionCost
19676000 usd
CY2021Q4 bgne Prepaid Construction Cost
PrepaidConstructionCost
24237000 usd
CY2022Q3 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
217000 usd
CY2021Q4 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
17162000 usd
CY2022Q3 bgne Rental Deposits And Other
RentalDepositsAndOther
6520000 usd
CY2021Q4 bgne Rental Deposits And Other
RentalDepositsAndOther
6609000 usd
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
96080000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
100792000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
140553000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
163049000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
142837000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
139966000 usd
CY2022Q3 bgne Accrued Liabilities External Research And Development
AccruedLiabilitiesExternalResearchAndDevelopment
114008000 usd
CY2021Q4 bgne Accrued Liabilities External Research And Development
AccruedLiabilitiesExternalResearchAndDevelopment
213922000 usd
CY2022Q3 bgne Accrued Expenses Commercial Activities
AccruedExpensesCommercialActivities
34646000 usd
CY2021Q4 bgne Accrued Expenses Commercial Activities
AccruedExpensesCommercialActivities
71560000 usd
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
25879000 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
45661000 usd
CY2022Q3 bgne Accrued Sales Rebates And Returns Current
AccruedSalesRebatesAndReturnsCurrent
49890000 usd
CY2021Q4 bgne Accrued Sales Rebates And Returns Current
AccruedSalesRebatesAndReturnsCurrent
59639000 usd
CY2022Q3 bgne Accrued Professional Fees And Other Current
AccruedProfessionalFeesAndOtherCurrent
42995000 usd
CY2021Q4 bgne Accrued Professional Fees And Other Current
AccruedProfessionalFeesAndOtherCurrent
27307000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
410255000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
558055000 usd
CY2022Q3 bgne Government Grants Or Incentives Received And Deferred Noncurrent
GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent
37700000 usd
CY2021Q4 bgne Government Grants Or Incentives Received And Deferred Noncurrent
GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent
46352000 usd
CY2022Q3 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
7330000 usd
CY2021Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
7814000 usd
CY2022Q3 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
139000 usd
CY2021Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
68000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
45169000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
54234000 usd
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
441275000 usd
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3138961000 cny
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
427565000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2724732000 cny
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
208058000 usd
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1480000000 cny
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
202113000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1288000000 cny
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
5596000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
16580000 usd
CY2022Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
527000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2462000 usd
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
7609000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
22186000 usd
CY2021Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
275000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
526000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-557556000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-438114000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1558480000 usd
us-gaap Net Income Loss
NetIncomeLoss
-867138000 usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1345303747 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1345303747 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1205971284 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1205971284 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1337976853 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1337976853 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1196391201 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1196391201 shares
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
78176000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
67077000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
225036000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
177701000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-179473000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-179473000 usd
CY2022Q3 bgne Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage
RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage
0.10
CY2022Q3 bgne Restricted Net Assets Required Statutory Reserve As Percentage Of Registered Capital
RestrictedNetAssetsRequiredStatutoryReserveAsPercentageOfRegisteredCapital
0.50
CY2022Q3 bgne Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage
RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage
0.10
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
142196000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
387628000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
206440000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1035826000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
962304000 usd

Files In Submission

Name View Source Status
0001651308-22-000209-index-headers.html Edgar Link pending
0001651308-22-000209-index.html Edgar Link pending
0001651308-22-000209.txt Edgar Link pending
0001651308-22-000209-xbrl.zip Edgar Link pending
bgne-20220930.htm Edgar Link pending
bgne-20220930.xsd Edgar Link pending
bgne-20220930_g1.jpg Edgar Link pending
exhibit101-nqagreementempl.htm Edgar Link pending
exhibit102-rsuagreementemp.htm Edgar Link pending
exhibit103-rsuagreementcon.htm Edgar Link pending
exhibit311-2022q3.htm Edgar Link pending
exhibit312-2022q3.htm Edgar Link pending
exhibit321-2022q3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
bgne-20220930_lab.xml Edgar Link unprocessable
bgne-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bgne-20220930_pre.xml Edgar Link unprocessable
bgne-20220930_def.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bgne-20220930_htm.xml Edgar Link completed